PureTech Issuance Of Capital Stock vs Net Income Analysis

PRTC Stock

USD 22.21 1.18 5.04%

PureTech Health financial indicator trend analysis is much more than just breaking down PureTech Health PLC prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PureTech Health PLC is a good investment. Please check the relationship between PureTech Health Issuance Of Capital Stock and its Net Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Issuance Of Capital Stock vs Net Income

Issuance Of Capital Stock vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PureTech Health PLC Issuance Of Capital Stock account and Net Income. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between PureTech Health's Issuance Of Capital Stock and Net Income is -0.07. Overlapping area represents the amount of variation of Issuance Of Capital Stock that can explain the historical movement of Net Income in the same time period over historical financial statements of PureTech Health PLC, assuming nothing else is changed. The correlation between historical values of PureTech Health's Issuance Of Capital Stock and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Issuance Of Capital Stock of PureTech Health PLC are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Issuance Of Capital Stock i.e., PureTech Health's Issuance Of Capital Stock and Net Income go up and down completely randomly.

Correlation Coefficient

-0.07

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Issuance Of Capital Stock

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in PureTech Health PLC financial statement analysis. It represents the amount of money remaining after all of PureTech Health PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from PureTech Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PureTech Health PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

At present, PureTech Health's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 8.14, whereas Issuance Of Capital Stock is forecasted to decline to about 1.1 M.

	2021	2022	2023	2024 (projected)
Interest Expense	4.7M	4.0M	13.5M	14.2M
Depreciation And Amortization	7.2M	8.9M	4.9M	7.0M

Interest Expense Depreciation And Amortization

PureTech Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.91	0.6	0.45	0.99	0.95	-0.16	-0.75	0.78	0.62	0.8	0.92	0.69	0.8	-0.13	0.71	0.12	0.81	0.61	0.64	0.87	0.91	0.81	0.65	-0.86	-0.12
Short Long Term Debt Total	0.91		0.49	0.28	0.91	0.94	-0.28	-0.75	0.87	0.54	0.82	0.85	0.86	0.71	-0.14	0.79	-0.08	0.74	0.57	0.37	0.7	0.9	0.72	0.8	-0.85	-0.14
Other Current Liab	0.6	0.49		0.9	0.55	0.5	0.31	-0.54	0.14	0.26	0.56	0.48	0.64	0.61	-0.21	0.2	0.18	0.2	0.47	0.72	0.82	0.44	0.61	0.51	-0.23	-0.21
Total Current Liabilities	0.45	0.28	0.9		0.41	0.3	0.66	-0.41	-0.12	0.32	0.41	0.28	0.47	0.58	-0.05	0.0	0.37	-0.01	0.32	0.78	0.77	0.23	0.57	0.43	0.0	-0.06
Total Stockholder Equity	0.99	0.91	0.55	0.41		0.95	-0.17	-0.72	0.79	0.65	0.77	0.93	0.67	0.79	-0.09	0.71	0.14	0.79	0.59	0.63	0.83	0.92	0.79	0.65	-0.88	-0.09
Property Plant And Equipment Net	0.95	0.94	0.5	0.3	0.95		-0.27	-0.67	0.89	0.61	0.74	0.93	0.73	0.67	-0.21	0.72	-0.02	0.77	0.61	0.47	0.73	0.97	0.68	0.59	-0.89	-0.2
Current Deferred Revenue	-0.16	-0.28	0.31	0.66	-0.17	-0.27		0.03	-0.52	0.0	-0.06	-0.28	-0.01	0.1	0.25	-0.52	0.27	-0.55	-0.17	0.3	0.17	-0.34	0.07	-0.04	0.56	0.25
Net Debt	-0.75	-0.75	-0.54	-0.41	-0.72	-0.67	0.03		-0.56	-0.27	-0.99	-0.55	-0.72	-0.83	-0.23	-0.69	0.15	-0.61	-0.64	-0.3	-0.71	-0.65	-0.83	-0.64	0.59	-0.23
Retained Earnings	0.78	0.87	0.14	-0.12	0.79	0.89	-0.52	-0.56		0.4	0.63	0.86	0.59	0.39	-0.15	0.71	-0.33	0.8	0.41	0.09	0.43	0.86	0.41	0.46	-0.9	-0.15
Accounts Payable	0.62	0.54	0.26	0.32	0.65	0.61	0.0	-0.27	0.4		0.32	0.49	0.4	0.6	-0.11	0.6	0.54	0.42	0.68	0.5	0.52	0.71	0.62	0.36	-0.62	-0.11
Cash	0.8	0.82	0.56	0.41	0.77	0.74	-0.06	-0.99	0.63	0.32		0.62	0.78	0.84	0.18	0.72	-0.14	0.64	0.65	0.32	0.73	0.72	0.84	0.69	-0.65	0.18
Non Current Assets Total	0.92	0.85	0.48	0.28	0.93	0.93	-0.28	-0.55	0.86	0.49	0.62		0.57	0.51	-0.2	0.56	-0.1	0.81	0.39	0.53	0.74	0.85	0.52	0.52	-0.87	-0.2
Non Currrent Assets Other	0.69	0.86	0.64	0.47	0.67	0.73	-0.01	-0.72	0.59	0.4	0.78	0.57		0.65	-0.14	0.63	-0.12	0.37	0.58	0.26	0.62	0.7	0.66	0.83	-0.52	-0.14
Cash And Short Term Investments	0.8	0.71	0.61	0.58	0.79	0.67	0.1	-0.83	0.39	0.6	0.84	0.51	0.65		0.04	0.71	0.42	0.55	0.74	0.64	0.81	0.7	1.0	0.67	-0.56	0.04
Common Stock Total Equity	-0.13	-0.14	-0.21	-0.05	-0.09	-0.21	0.25	-0.23	-0.15	-0.11	0.18	-0.2	-0.14	0.04		-0.17	-0.22	-0.19	-0.14	-0.22	-0.16	-0.2	0.03	-0.02	0.12	1.0
Common Stock Shares Outstanding	0.71	0.79	0.2	0.0	0.71	0.72	-0.52	-0.69	0.71	0.6	0.72	0.56	0.63	0.71	-0.17		0.09	0.8	0.76	0.18	0.51	0.8	0.73	0.61	-0.84	-0.17
Short Term Investments	0.12	-0.08	0.18	0.37	0.14	-0.02	0.27	0.15	-0.33	0.54	-0.14	-0.1	-0.12	0.42	-0.22	0.09		-0.06	0.26	0.62	0.25	0.08	0.42	0.06	0.05	-0.22
Non Current Liabilities Total	0.81	0.74	0.2	-0.01	0.79	0.77	-0.55	-0.61	0.8	0.42	0.64	0.81	0.37	0.55	-0.19	0.8	-0.06		0.47	0.34	0.63	0.75	0.56	0.45	-0.92	-0.18
Other Current Assets	0.61	0.57	0.47	0.32	0.59	0.61	-0.17	-0.64	0.41	0.68	0.65	0.39	0.58	0.74	-0.14	0.76	0.26	0.47		0.3	0.55	0.76	0.77	0.32	-0.59	-0.14
Other Stockholder Equity	0.64	0.37	0.72	0.78	0.63	0.47	0.3	-0.3	0.09	0.5	0.32	0.53	0.26	0.64	-0.22	0.18	0.62	0.34	0.3		0.82	0.41	0.62	0.39	-0.32	-0.22
Total Liab	0.87	0.7	0.82	0.77	0.83	0.73	0.17	-0.71	0.43	0.52	0.73	0.74	0.62	0.81	-0.16	0.51	0.25	0.63	0.55	0.82		0.66	0.8	0.62	-0.59	-0.16
Property Plant And Equipment Gross	0.91	0.9	0.44	0.23	0.92	0.97	-0.34	-0.65	0.86	0.71	0.72	0.85	0.7	0.7	-0.2	0.8	0.08	0.75	0.76	0.41	0.66		0.73	0.52	-0.91	-0.2
Total Current Assets	0.81	0.72	0.61	0.57	0.79	0.68	0.07	-0.83	0.41	0.62	0.84	0.52	0.66	1.0	0.03	0.73	0.42	0.56	0.77	0.62	0.8	0.73		0.66	-0.58	0.03
Short Term Debt	0.65	0.8	0.51	0.43	0.65	0.59	-0.04	-0.64	0.46	0.36	0.69	0.52	0.83	0.67	-0.02	0.61	0.06	0.45	0.32	0.39	0.62	0.52	0.66		-0.5	-0.02
Intangible Assets	-0.86	-0.85	-0.23	0.0	-0.88	-0.89	0.56	0.59	-0.9	-0.62	-0.65	-0.87	-0.52	-0.56	0.12	-0.84	0.05	-0.92	-0.59	-0.32	-0.59	-0.91	-0.58	-0.5		0.12
Common Stock	-0.12	-0.14	-0.21	-0.06	-0.09	-0.2	0.25	-0.23	-0.15	-0.11	0.18	-0.2	-0.14	0.04	1.0	-0.17	-0.22	-0.18	-0.14	-0.22	-0.16	-0.2	0.03	-0.02	0.12

Click cells to compare fundamentals

PureTech Health Account Relationship Matchups

PureTech Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	941.2M	990.0M	946.0M	702.6M	694.0M	544.9M
Short Long Term Debt Total	39.3M	76.6M	52.0M	46.9M	25.3M	26.1M
Other Current Liab	101.5M	141.1M	205.3M	57.9M	29.6M	28.2M
Total Current Liabilities	139.2M	180.9M	226.1M	96.9M	51.4M	48.8M
Total Stockholder Equity	668.0M	669.7M	593.5M	542.2M	464.1M	367.8M
Property Plant And Equipment Net	43.8M	42.9M	43.9M	37.2M	19.4M	19.9M
Current Deferred Revenue	22.2M	22.6M	31.3M	2.2M	(29.5M)	(28.0M)
Net Debt	(93.1M)	(327.3M)	(413.7M)	(103.0M)	(165.7M)	(174.0M)
Retained Earnings	254.4M	260.4M	199.9M	149.5M	83.8M	88.0M
Accounts Payable	11.1M	8.9M	11.3M	26.5M	14.6M	10.4M
Cash	132.4M	403.9M	465.7M	149.9M	191.1M	180.3M
Non Current Assets Total	772.3M	575.6M	444.2M	316.5M	346.8M	257.8M
Non Currrent Assets Other	32.3M	531.9M	399.3M	278.4M	879K	835.1K
Cash And Short Term Investments	162.4M	403.9M	465.7M	350.1M	327.1M	273.9M
Common Stock Total Equity	4.7M	5.4M	5.4M	5.4M	4.9M	4.6M
Common Stock Shares Outstanding	29.2M	292.9M	286.6M	284.8M	276.3M	290.1M
Short Term Investments	30.1M	(1.7M)	(1.3M)	200.2M	136.1M	93.3M
Liabilities And Stockholders Equity	941.2M	990.0M	946.0M	702.6M	694.0M	544.9M
Non Current Liabilities Total	151.6M	155.5M	135.7M	58.2M	184.4M	193.6M
Other Current Assets	1.9M	7.5M	32.5M	23.8M	17.7M	11.1M
Other Stockholder Equity	408.2M	265.4M	249.7M	263.1M	245.6M	279.0M
Total Liab	290.8M	336.5M	361.9M	155.1M	235.7M	223.8M
Property Plant And Equipment Gross	43.8M	42.9M	58.3M	57.3M	32.3M	24.3M
Total Current Assets	168.8M	414.3M	501.8M	386.2M	347.2M	287.1M
Accumulated Other Comprehensive Income	(18.3M)	(23.6M)	(39.6M)	(14.4M)	129.1M	135.6M
Short Term Debt	4.4M	29.7M	9.4M	12.5M	7.1M	9.8M
Intangible Assets	625K	899K	987K	831K	906K	860.7K
Common Stock	5.4M	5.4M	5.4M	5.5M	5.5M	5.2M
Other Liab	116.7M	108.6M	92.4M	23.8M	27.3M	26.0M
Net Tangible Assets	667.4M	668.8M	592.5M	541.4M	622.6M	490.8M
Other Assets	819K	2.3M	1K	2.1M	1.0	0.95
Net Receivables	2.3M	2.9M	3.6M	12.3M	2.4M	3.7M
Short Long Term Debt	1.5M	26.5M	4.8M	7.5M	3.7M	7.0M
Non Current Liabilities Other	1.8M	138K	(1K)	1K	110.2M	115.7M
Property Plant Equipment	8.3M	43.8M	42.9M	43.9M	50.5M	28.0M
Net Invested Capital	669.5M	711.0M	612.5M	560.0M	467.8M	554.7M
Net Working Capital	29.6M	233.4M	275.7M	289.3M	295.8M	163.8M
Capital Lease Obligations	37.8M	35.3M	33.0M	29.1M	21.6M	28.8M
Capital Stock	5.4M	5.4M	5.4M	5.5M	5.5M	6.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:

How To Invest In PureTech

Details

Is PureTech Stock a good investment?

Details

What is PureTech Health's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.615

Earnings Share

(3.00)

Revenue Per Share

0.02

Quarterly Revenue Growth

(0.91)

Return On Assets

(0.13)

The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PureTech Issuance Of Capital Stock vs Net Income Analysis

Issuance Of Capital Stock vs Net Income

Issuance Of Capital Stock vs Net Income Correlation Analysis

Correlation Coefficient

Issuance Of Capital Stock

Net Income

PureTech Health fundamental ratios Correlations

PureTech Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PureTech Health fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.97	Property Plant And Equipment Net
Property Plant And Equipment Net	+ 0.95	Total Assets
Property Plant And Equipment Net	+ 0.95	Total Stockholder Equity

Cash	- 0.99	Net Debt
Intangible Assets	- 0.92	Non Current Liabilities Total
Intangible Assets	- 0.91	Property Plant And Equipment Gross
Intangible Assets	- 0.9	Retained Earnings
Intangible Assets	- 0.89	Property Plant And Equipment Net
Intangible Assets	- 0.88	Total Stockholder Equity